Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China.

We conducted a population-based case-control study in Xuan Wei, China, where lung cancer rates are among the highest in China due to exposure to indoor coal combustion products, to evaluate the association between polymorphisms in immunoregulatory genes and lung cancer risk. A total of 122 incident primary lung cancer cases and 122 individually matched controls were enrolled in Xuan Wei, China. Fifty single-nucleotide polymorphisms (SNPs) in 23 immunoregulatory genes involved in inflammation were genotyped and analyzed by logistic regression to assess the risk of lung cancer. A global test of association for 42 SNPs, which excluded eight SNPs that were in very tight linkage disequilibrium with other SNPs, was statistically significant (P = 0.01), suggesting that overall genetic variation in this pathway contributes to lung cancer risk. In addition, the IL1B -1060TT (i.e. -511TT) genotype was associated with increased lung cancer risk compared with the CC genotype [odds ratio (OR) = 2.27, 95% confidence interval (CI) = 1.05-4.91]. The IL8RA Ex2+860 GC or CC (OR = 0.27, 95% CI = 0.11-0.67), ICAM1 Ex2+100 AT or TT (OR = 0.39, 95% CI = 0.18-0.88) and IL12A Ex7+277 GA or AA (OR = 0.43, 95% CI = 0.22-0.84) genotypes were associated with decreased lung cancer risk. The protective effect of the IL8RA variant was stronger among subjects with high cumulative smoky coal use (> or = 130 tons) (OR = 0.11, 95% CI = 0.03-0.44; P(interaction) = 0.03). In conclusion, genetic variation in immunoregulatory genes may play an important role in the development of lung cancer in this population.

[1]  S. Berndt,et al.  GST genotypes and lung cancer susceptibility in Asian populations with indoor air pollution exposures: a meta-analysis. , 2007, Mutation research.

[2]  L. Hou,et al.  Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. , 2007, Carcinogenesis.

[3]  Hugues Sicotte,et al.  SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes , 2005, Nucleic Acids Res..

[4]  D. Phillips,et al.  Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin 1 beta gene. , 2005, Lung cancer.

[5]  A. Bateman,et al.  ICAM‐1 polymorphisms and development of cutaneous malignant melanoma , 2005, International journal of immunogenetics.

[6]  Astrid Dempfle,et al.  TNF-α, TNF-β, IL-6, and IL-10 Polymorphisms in Patients with Lung Cancer , 2005, Disease markers.

[7]  Qing Lan,et al.  Improvement in household stoves and risk of chronic obstructive pulmonary disease in Xuanwei, China: retrospective cohort study , 2005, BMJ : British Medical Journal.

[8]  L. Cavalli-Sforza,et al.  Molecular Evolution of CXCR1, a G Protein-Coupled Receptor Involved in Signal Transduction of Neutrophils , 2005, Journal of Molecular Evolution.

[9]  M. Rugge,et al.  Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals , 2005, Journal of Medical Genetics.

[10]  J. Epplen,et al.  Association of interleukin-8 receptor α polymorphisms with chronic obstructive pulmonary disease and asthma , 2005, Genes and Immunity.

[11]  Nathan J Markward,et al.  Large-Scale Association Study Identifies ICAM Gene Region as Breast and Prostate Cancer Susceptibility Locus , 2004, Cancer Research.

[12]  A. Malkinson,et al.  Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[13]  A. Mantovani,et al.  IL‐8 induces a specific transcriptional profile in human neutrophils: synergism with LPS for IL‐1 production , 2004, European journal of immunology.

[14]  F. Breedveld,et al.  Correlation of polymorphic variation in the promoter region of the interleukin‐1β gene with secretion of interleukin‐1β protein , 2004 .

[15]  F. Canzian,et al.  Polymorphisms of the interleukin‐1 β gene are associated with increased risk of non‐small cell lung cancer , 2004, International journal of cancer.

[16]  Nathaniel Rothman,et al.  Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies , 2004 .

[17]  Vidar Skaug,et al.  Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. , 2003, Carcinogenesis.

[18]  G. Colditz,et al.  A meta-analysis of asthma and risk of lung cancer (United States) , 2003, Cancer Causes & Control.

[19]  F. Marincola,et al.  Cytokine polymorphism and its possible impact on cancer , 2004, Immunologic research.

[20]  Juliet M Chapman,et al.  Detecting Disease Associations due to Linkage Disequilibrium Using Haplotype Tags: A Class of Tests and the Determinants of Statistical Power , 2003, Human Heredity.

[21]  Albert Duschl,et al.  The diesel exhaust component pyrene induces expression of IL-8 but not of eotaxin. , 2003, International immunopharmacology.

[22]  E. Silverman,et al.  Genome-wide linkage analysis of bronchodilator responsiveness and post-bronchodilator spirometric phenotypes in chronic obstructive pulmonary disease. , 2003, Human molecular genetics.

[23]  Y. Nakanishi,et al.  Polycyclic aromatic hydrocarbons induce IL-8 expression through nuclear factor kappaB activation in A549 cell line. , 2002, Cytokine.

[24]  G. Morahan,et al.  Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children , 2002, The Lancet.

[25]  Q. Lan,et al.  Household stove improvement and risk of lung cancer in Xuanwei, China. , 2002, Journal of the National Cancer Institute.

[26]  D. Schaid,et al.  Score tests for association between traits and haplotypes when linkage phase is ambiguous. , 2002, American journal of human genetics.

[27]  Jacques Ferlay,et al.  Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.

[28]  F. Fitzpatrick,et al.  Inflammation, carcinogenesis and cancer. , 2001, International immunopharmacology.

[29]  K J O'Byrne,et al.  Chronic immune activation and inflammation as the cause of malignancy , 2001, British Journal of Cancer.

[30]  M. Tang,et al.  Important roles for L-selectin and ICAM-1 in the development of allergic airway inflammation in asthma. , 2001, Pulmonary pharmacology & therapeutics.

[31]  K. Buetow,et al.  Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[32]  G. Morahan,et al.  Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele , 2001, Nature Genetics.

[33]  D. Postma,et al.  Major genes regulating total serum immunoglobulin E levels in families with asthma. , 2000, American journal of human genetics.

[34]  N. Rothman,et al.  Indoor coal combustion emissions, GSTM1 and GSTT1 genotypes, and lung cancer risk: a case-control study in Xuan Wei, China. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[35]  M. Carrington,et al.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.

[36]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[37]  D. B. Harris,et al.  The epidemiology of lung cancer in Xuan Wei, China: current progress, issues, and research strategies. , 1988, Archives of environmental health.

[38]  J. Chuang,et al.  Lung cancer and indoor air pollution in Xuan Wei, China. , 1987, Science.

[39]  U. Mohr,et al.  Lung tumours in rats and mice after inhalation of PAH-rich emissions. , 1986, Experimental pathology.

[40]  S. Permutt,et al.  A COMMON FAMILIAL COMPONENT IN LUNG CANCER AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE , 1977, The Lancet.

[41]  J. Hockaday,et al.  PROLACTIN AND MIGRAINE , 1974 .